missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ NALP7 Polyclonal Antibody

Description
Immunogen sequence: CRLTEASCKD LAAVLVVSKK LTHLCLAKNP IGDTGVKFLC EGLSYPDCKL QTLVLQQCSI TKLGCRYLSE ALQEACSLTN LDLSINQIAR GLWILCQALE NPNCNLKHLR LWSCSLMPFY CQHLGSALLS NQKLETLDLG QNHLWKSGII KLFGVLRQRT GSLKILRLKT YETNLEIKKL LEEVKEKNPK LTIDCNASGA T; Positive Samples: HeLa, U-87MG, 293T, Jurkat, Mouse brain.
NOD proteins include the apoptosis regulator APAF1 (apoptotic protease activating factor 1) and mammalian NOD-LRR proteins. NALP7, also known as PYPAF3, a member of the related PYRIN-containing APAF1-like proteins (PYPAFs/NALPs) is thought to play a crucial role in cell proliferation. NALP7 has a C-terminal leucine-rich repeat (LRR) region, an N-terminal Pyrin domain (PYD) followed by a NACHT domain, and a NACHT-associated domain. It is expressed in numerous tissues including uterus and ovary, with low levels in heart and brain. NALP7 inhibits caspase-1-dependent interleukin-1-b secretion and is a feedback regulator of interleukin-1-b secretion. Defects in the NALP7 gene are known to cause the formation of a hydatidiform mole (HYDM) and reduce the growth of carcinoma cell lines.
Spécifications
Spécifications
| Antigène | NALP7 |
| Applications | ELISA, Western Blot |
| Classification | Polyclonal |
| Concentration | 2.24 mg/mL |
| Conjugué | Unconjugated |
| Formule | PBS with 50% glycerol and 0.01% thimerosal; pH 7.3 |
| Gène | NLRP7 |
| Numéro d’acquisition du gène | Q8WX94 |
| Alias du gène | CLR19.4; HYDM; NACHT, leucine rich repeat and PYD containing 7; NACHT, LRR and PYD containing protein 7; NACHT, LRR and PYD domains-containing protein 7; NALP7; NLR family pyrin domain containing 7; NLR family, pyrin domain containing 7; NLRP7; NOD12; Nucleotide-binding oligomerization domain protein 12; nucleotide-binding oligomerization domain, leucine rich repeat and pyrin domain containing 7; PAN7; PYPAF3; PYRIN-containing APAF1-like protein 3 |
| Symboles de gène | NLRP7 |
| Afficher plus de résultats |